By Lilian Massihi, MD, Board-Certified Family Medicine, Advanced BHRT Certification
You weigh what you weighed two years ago. The number has barely moved. And yet your arms look softer than they used to, your jeans fit differently even though the size is the same, and the grocery bags feel heavier walking in from the car than they did when you were forty-two.
So you mention it. And because your weight is stable, the conversation ends there. Nothing to address. Maybe eat a little cleaner, add some cardio, and try not to worry about it.
The short answer: Your weight can hold perfectly steady while the two things that make up that weight move in opposite directions. Across the menopause transition, the rate of fat gain roughly doubles and lean mass shifts from slowly increasing to actively declining. Those two changes very nearly cancel each other out on a bathroom scale, which is why the number stays quiet while your body does not. Menopause muscle loss is measured, it is timed to the transition rather than to your age, and it is the single most common reason a woman is told nothing has changed when something clearly has.
The Scale Is Averaging Two Opposite Changes
The Study of Women’s Health Across the Nation followed women through the menopause transition and measured body composition rather than weight alone. The findings are worth reading slowly.
- Before the transition, fat mass rose about 1.0 percent per year. During the transition, that rate accelerated to 1.7 percent per year.
- Before the transition, lean mass was still slowly increasing, by about 0.2 percent per year. During the transition, it began decreasing, by about 0.2 percent per year.
- Over the roughly three and a half years of the transition, that worked out to a 6 percent gain in fat mass and a 0.5 percent loss in lean mass in the average participant.
Now the part that explains your experience. The researchers went looking for why body weight shows no dramatic change during a period when body composition changes so much, and they found the arithmetic sitting right there. Compared with the years before the transition, fat mass was accumulating an extra 199 grams per year while lean mass was disappearing at an extra 119 grams per year. Add those together and the net difference in what the scale sees is about 80 grams per year.
Eighty grams. Under three ounces. That is the signal your scale is giving you, and it is dwarfed by the two changes underneath it that are five and eight times larger and pointing in opposite directions.
You were not imagining the change. You were reading the wrong instrument, because it is the only instrument anybody handed you.
Menopause Muscle Loss Tracks the Transition, Not Your Birthday
The usual explanation for menopause muscle loss is that muscle declines with age and you are getting older. That is true as far as it goes, and it is not what the data describes here.
In the same analysis, the direction of change in lean mass flipped at the onset of the transition, not at a particular age. It then continued until roughly two years past the final menstrual period, at which point both the fat and lean trajectories decelerated toward a flat line. A process that starts when the transition starts, runs while it runs, and settles when it settles is behaving like a feature of the transition.
The researchers also checked whether race, ethnicity, or the age at which a woman reached her final period changed the lean mass trajectory. None of them did. The lean mass pattern looked the same across all four groups studied. Whatever is driving this is not a lifestyle variable and it is not chronological age alone.
What Estrogen Is Actually Doing in Muscle
Skeletal muscle is not a passive bystander to hormonal change. It carries estrogen receptors, principally estrogen receptor alpha, and those receptors sit on pathways that govern how muscle protein is broken down and how muscle repairs itself.
Two lines of work are worth knowing about. Muscle maintains a population of resident stem cells, called satellite cells, that handle repair and regeneration, and experimental work has shown estrogen is involved in maintaining that compartment. Separately, in early postmenopausal women, short-term estradiol administration reduced markers of skeletal muscle protein breakdown. Notably, that effect appeared in women who were early postmenopausal and not in women who were further out.
So the biology is real, it is specific, and it is not mysterious. Which makes what comes next more important, not less.
Here Is the Part Most Hormone Practices Leave Out
If you have read this far, you can probably see where a hormone practice would usually take this. Estrogen acts on muscle, estrogen declines, therefore replace the estrogen and protect the muscle. It is a clean story and I am not going to tell it to you, because the evidence does not support it.
The best available synthesis found no significant effect of hormone therapy on lean body mass. A systematic review and meta-analysis published in JAMA Network Open in 2019 pooled 12 randomized clinical trials covering 4,474 women, with a median follow-up of two years. Women on hormone therapy lost 0.06 kg less lean mass than women who were not, a difference that was not statistically significant. The result held when the authors sorted the trials by hormone type, by dose, by how long women were followed, by how long since menopause, by study quality, and by how lean mass was measured. No subgroup reached significance.
The SWAN analysis discussed above reached the same place from a completely different direction: hormone therapy use did not independently predict change in lean mass, fat mass, weight, or BMI in that cohort either.
The same applies to testosterone, and this one matters because of how it is marketed. The Global Consensus Position Statement on the Use of Testosterone Therapy for Women, endorsed by the International Menopause Society, The Endocrine Society, and The North American Menopause Society among others, states that at the doses studied, no statistically significant effect of testosterone has been demonstrated on lean body mass, total body fat, or muscle strength. That is their highest evidence grade. The statement is equally direct that the one evidence-based indication for testosterone therapy in women is hypoactive sexual desire disorder, and that data are insufficient to support other uses.
You will find clinics selling testosterone to women as a body composition treatment. The professional bodies that reviewed the trials do not support that use, and neither do I.
What Does Work Is Less Convenient and It Is Not a Prescription
Resistance training and adequate protein are the interventions with evidence behind them for this specific problem.
A systematic review and meta-analysis of randomized trials in menopausal women found resistance training had a measurable effect on lean body mass, with the stronger effects showing up in programs that ran longer than twelve weeks and met around three sessions a week. Protein intake amplifies that effect: multiple meta-analyses of resistance training with added dietary protein show greater gains in lean mass than training alone.
I want to be accurate about the size of this. These are described in the literature as small to moderate effects, not transformations. You are working against a physiological headwind, and the goal is to change the slope rather than to reverse it. That is still very much worth doing, because the slope compounds over decades and because muscle is the tissue that determines whether you can carry your own groceries at seventy-five.
Then Why Does Hormone Therapy Belong in This Conversation At All
Because of what it is genuinely indicated for, and because of what that makes possible.
Hormone therapy has strong evidence for the symptoms of the transition itself: vasomotor symptoms, sleep disruption, genitourinary changes, and bone density. What I see clinically is that those symptoms are frequently the reason a resistance training program never gets off the ground. A woman waking at three in the morning with her heart pounding, aching in her hips and shoulders, and running on four hours of sleep is not going to start lifting three times a week, and telling her to try harder is not a treatment plan.
That is an honest, indirect mechanism and I am naming it as indirect. Treating the transition well is not a muscle intervention. It removes some of the obstacles standing between you and the intervention that is.
This is the same logic behind why the scale goes up for many women during perimenopause, which is a related but separate mechanism involving sleep, cortisol, and where the body chooses to store fat. Read that one if the number on your scale has moved. This article is about the case where it has not.
Measure the Thing You Actually Care About
If your concern is your body composition, then weight is not the measurement that answers it, and neither is BMI. Both collapse fat and lean tissue into one number, which is precisely the number that stays flat while the two components move apart.
A useful evaluation looks at body composition directly and at the metabolic markers that travel with these changes rather than at weight in isolation. Fasting insulin and markers of insulin sensitivity matter here, because loss of lean tissue and gain of visceral fat both push glucose handling in the same unhelpful direction. Thyroid function deserves a proper look, since it drives energy availability and gets blamed for and cleared of these symptoms in the same appointment. And it is worth knowing where your hormone levels actually sit, not to prescribe your way out of muscle loss, but because the rest of the transition is treatable and there is no reason to leave it untreated while you do the strength work.
What I would not do is accept a stable weight as evidence that nothing has changed. That is the one conclusion the measurement cannot support.
Frequently Asked Questions
How can I be losing muscle if my weight has not changed?
Because weight is the sum of tissues that are moving in opposite directions. Across the menopause transition, the annual rate of fat accumulation increases by roughly 199 grams per year while lean mass declines by roughly 119 grams per year compared with the preceding years. The net effect on the scale is about 80 grams per year, which is far too small to notice, while the underlying changes are large enough to see in a mirror and feel in your strength.
Will hormone therapy rebuild the muscle I have lost?
No, and you should be skeptical of anyone who tells you it will. A meta-analysis of 12 randomized trials covering 4,474 women found no statistically significant effect of hormone therapy on lean body mass, and that finding held across every subgroup examined. Hormone therapy has good evidence for the symptoms of the transition. Muscle mass is not one of its established effects.
What about testosterone? I have read it helps women build muscle.
The Global Consensus Position Statement on testosterone therapy for women, endorsed by the major international menopause and endocrine societies, concluded that at the doses studied no significant effect on lean body mass, total body fat, or muscle strength has been demonstrated. The only evidence-based indication identified was hypoactive sexual desire disorder. Testosterone has a legitimate clinical role in women. Body composition is not currently one of its supported uses.
Is this just aging?
Aging contributes, but the timing argues against aging alone. In the SWAN data the direction of lean mass change reversed at the onset of the menopause transition rather than at a particular age, continued through it, and flattened roughly two years after the final menstrual period. The pattern also held regardless of race, ethnicity, or the age at which a woman reached her final period.
How much resistance training does the research actually support?
The randomized trial evidence in menopausal women points to programs lasting longer than twelve weeks at around three sessions per week, with adequate dietary protein alongside. The measured effects on lean mass are described as small to moderate. That is a real effect and an honest one, and it is currently the best-supported thing you can do about this specific problem.
What should I ask to have measured?
Body composition rather than weight or BMI alone, along with the metabolic and hormonal markers that move with it. AllureMD’s metabolic and weight support evaluation is built around exactly this question: what is actually changing in your body, as opposed to what the scale is willing to tell you about it.
AllureMD is a physician-led hormone optimization practice in Madison, Mississippi. If your weight has held steady while your body has not, metabolic and weight support at AllureMD starts by measuring what is actually changing. Lilian Massihi, MD evaluates each patient’s complete hormonal and metabolic picture before making any recommendation. To schedule your consultation, book a complimentary discovery call.
About the Author
Lilian Massihi, MD is a board-certified family medicine physician and hormone optimization specialist who completed her undergraduate education at UCLA, earned her medical degree at the University of Poznań, and finished her residency at the University of Mississippi Medical Center. For more than five years, she practiced as a hospitalist, treating patients in the late stages of cardiovascular disease, cognitive decline, and severe osteoporosis. She kept asking the same question: what would have been different if someone had intervened sooner? That question led her to bioidentical hormone therapy, where a rigorous review of the evidence changed the direction of her career. She founded AllureMD in Madison, Mississippi to practice the kind of medicine she had come to believe in: treating the entire hormonal system, titrating to how patients actually feel, with a physician leading every decision.